# China%20Healthcare
Latest news and articles about China%20Healthcare
Total: 15 articles found
Navigating the Labyrinth: The Rise and Growing Pains of China’s Medical Companions
China is witnessing the emergence of 'medical companions' to help the elderly and lonely youth navigate a digitized healthcare system. While the industry faces regulatory voids and predatory certification scams, government pilot programs signal a shift toward official professionalization by 2026.
Weiguang Bio Advances Patient-Centric Care with Subcutaneous Immunoglobulin Trial Approval
Weiguang Biological has received NMPA approval to begin clinical trials for a subcutaneous human immunoglobulin injection. The therapy targets primary immunodeficiency diseases and represents a shift toward home-based, patient-friendly administration in the Chinese plasma market.
China’s Fountain of Youth: The Dangerous Rise of the Underground Stem Cell Market
China is witnessing a surge in illegal stem cell infusions marketed as high-priced anti-aging treatments, often involving collusion between private firms and public hospital doctors. Despite costs reaching $55,000 per shot, there is no scientific evidence or regulatory approval for these therapies, posing significant health and financial risks to consumers.